市場調査レポート

新たな自閉症診断

Novel Autism Diagnostics

発行 Kalorama Information 商品コード 353998
出版日 ページ情報 英文 103 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
新たな自閉症診断 Novel Autism Diagnostics
出版日: 2016年02月05日 ページ情報: 英文 103 Pages
概要

疾病対策センター (CDC) によると、米国の子供68人に1人が社会的不適応・関心の狭さから深刻なコミュニケーション・知的障害までにおよぶ多くの症候群を含む自閉症スペクトラム障害 (ASD) を患っています。医師の診断および自閉症のような慢性疾患のモニターに役立つコスト効果的な検査の需要は拡大しています。

当レポートでは、ポイントオブケア (POC) の分子診断市場について調査分析し、主要セグメントに焦点を当てて、現在の売上高、市場の機会について、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 新たな自閉症診断

  • 自閉症の概要
  • 検査・診断
  • 発展的検査
  • 包括的な診断評価
  • 新しい診断
  • 潜在市場
  • 研究

第3章 企業プロファイル

  • Ambry Genetics Corp.
  • ARUP Laboratories
  • Asuragen Inc.
  • Athena Diagnostics, Inc. (A Quest Diagnostics Business)
  • Claritas Genomics, Inc.
  • CombiMatrix Corp.
  • Courtagen Life Sciences, Inc.
  • Emory Genetics Laboratory
  • GenePeeks, Inc.
  • Genoma SA (the Esperite group 子会社)
  • Google Genomics
  • Greenwood Genetic Center
  • Illumina
  • CLIA Lab Service
  • IntegraGen
  • LabCorp, Laboratory Corporation of America
  • BRCA Saga
  • Life Technologies
  • Lineagen, Inc.
  • MEDomics, LLC
  • Population Diagnostics
  • RainDance Technologies, Inc.
  • SynapDx Corporation
  • Transgenomic, Inc. 、ほか

図表

目次
Product Code: KLI5876130

Autism spectrum disorder (ASD), which now affects 1 in every 68 U.S. children per the Centers for Disease Control and Prevention (CDC), includes many syndromes that can range in severity from the social awkwardness and narrow interests to severe communication and intellectual disabilities. There is a growing demand for cost efficient tests that can help physicians diagnose and monitor chronic diseases such autism. Novel Autism Diagnostics examines selected autism test innovations that have emerged.

A diagnosis of ASD is arrived at via a combination of developmental screening and comprehensive diagnostic evaluation. In developmental screening, doctors test to see if children are learning basic skills when they should, or if they might have delays. A comprehensive diagnostic evaluation is needed if a doctor sees any signs of a problem. There is an emphasis on early detection as a future cost saving measure because therapy can be implemented when it can be most effective. Therefore there is a market opportunity for highly sensitive, specific and cost effective screening tests for early diagnosis.

Novel Autism Diagnostics outlines many of the current approaches to autism testing, including molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well.

Until a few years ago, genomic research had failed to decisively associate individual genes with the disorder. Numerous studies have been undertaken to uncover the genetic basics of autism. Next-generation sequencing technology has enabled unbiased assessments of whole genomes and exomes and a number of new tests and test services have been launched.

The competitors discussed within the company profiles are:

  • Ambry Genetics Corp.
  • ARUP Laboratories
  • Asuragen
  • Athena Diagnostics
  • Claritas Genomics
  • CombiMatrix
  • Courtagen Life Sciences
  • Emory Genetics Lab
  • GenePeeks
  • Genoma SA
  • Google Genomics
  • Greenwood Genetic Center
  • Illumina
  • IntegraGen
  • LabCorp
  • Life Technologies
  • Population Diagnostics
  • RainDance Technologies
  • SynapDx Corporation
  • Transgenomic, Inc.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Overview of ASD
  • Leading Competitors
  • Methodology

TWO: NOVEL AUTISM DIAGNOSTICS

  • Overview of Autism
  • Screening and Diagnosis
  • Developmental Screening
  • Comprehensive Diagnostic Evaluation
  • Emerging Diagnostics
  • Potential Market
  • Research

THREE: COMPANY PROFILES

  • Ambry Genetics Corp.
  • ARUP Laboratories
  • Asuragen Inc.
  • Controls
  • Sample Collection
  • Sequencing
  • Athena Diagnostics, Inc. (A Quest Diagnostics Business)
  • Claritas Genomics, Inc.
  • CombiMatrix Corp.
  • Oncology
  • Courtagen Life Sciences, Inc.
  • Emory Genetics Laboratory
  • GenePeeks, Inc.
  • Genoma SA (a Subsidiary of the Esperite group)
  • Google Genomics
  • Greenwood Genetic Center
  • Illumina
  • Sequencing
  • Sequencing Kits
  • Sample Prep
  • IVD Business
  • Oncology
  • HLA Typing
  • IT
  • Forensics
  • CLIA Lab Service
  • Nanopore Sequencing
  • Sample to Insight
  • Making a Market
  • IP Situation
  • IntegraGen
  • LabCorp, Laboratory Corporation of America
  • Infectious Diseases
  • Prenatal
  • Sequencing
  • Oncology
  • BRCA Saga
  • Information Technology
  • Forensic
  • Collaborations
  • Life Technologies Corporation
  • Instrumentation and Applications
  • Liquid Biopsy
  • Sequencing
  • Life Technologies an IVD Company
  • Partnerships Worldwide
  • Life and Quidel Develop Diagnostics on the 7500 Fast Dx
  • Sepsis
  • HIV
  • Emerging Pathogens
  • Bacterial Typing
  • Personalized Medicine
  • Forensic
  • Lineagen, Inc.
  • MEDomics, LLC
  • Population Diagnostics
  • RainDance Technologies, Inc.
  • SynapDx Corporation
  • Transgenomic, Inc.

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

  • Table 1-1: Identified Prevalence of Autism Spectrum Disorder (ADDM Network, 2000-2010)

TWO: NOVEL AUTISM DIAGNOSTICS

  • Table 2-1: Selected Autism Test Innovations
  • Table 2-2: Global Clinical Laboratory Services Market for Neonatal and Pediatric Testing, 2015 and 2020
  • Table 2-3: Geographical Distribution of Laboratories Performing Genetic Testing Services
Back to Top